<http://webisa.webdatacommons.org/prov/24040630>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/150039327> .
<http://webisa.webdatacommons.org/150039327>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/150039327>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<businesswire.com> .
<http://webisa.webdatacommons.org/150039327>	<http://www.w3.org/ns/prov#value>	"LONDON--(BUSINESS WIRE)--GlaxoSmithKline and Archemix Corp. today announced a worldwide strategic alliance to discover, develop and commercialise aptamer therapeutics to treat inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease." .
<http://webisa.webdatacommons.org/prov/436841133>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/150039327> .